Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
46
NCT06046534
Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.
Phase: N/A
Role: Collaborator
Start: Oct 27, 2023
Completion: Jun 10, 2024